Cancer Treatments

New York, United States, Nov. 23, 2022 (GLOBE NEWSWIRE) -- A biosimilar is a generic version of a well-known biologic drug. Biologic drugs are medicines made from living things like…

Anti-Cancer activity of BriaCell’s lead candidate, Bria-IMT™, in advanced breast cancer patients was published in a leading peer-reviewed publication. Bria-IMT™, through a novel mechanism…

, was a small pilot designed to test whether participants were able to fulfill the time commitment for the discussion group meetings and at-home practice exercises of the intervention, and…

said Abigail Kelly, a research assistant at Harvard Medical School's Beth Israel Deaconess Medical Center in Boston. Research from various…